Biogen announced complete results from the phase 3 VALOR study of tofersen (BIIB067), an antisense drug under development for patients with superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis…
The University of California San Diego (UCSD) School of Medicine received $4 million thanks to the California Institute for Regenerative Medicine (CIRM) to advance studies…
Principal investigator Shulin Ju and co-investigator Quan Zhong, two associate professors of biological sciences at Wright State University, received a $450,000 grant to research the neurological…
Kadimastem, an Israeli biopharma venture, recently declared it was hoping to discuss with the U.S. Food and Drug Administration (FDA) its AstroRX cells experimental therapy,…
The AMG Center for ALS at Mass General recently announced, along with Amylyx Pharmaceuticals, Inc., that AMX0035 demonstrated a significant treatment benefit for people with ALS…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
